Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
JMIR Research Protocols|April 25, 2020
The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility TrialMarie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, et al.
Pilot and Feasibility Studies|February 27, 2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) ProgramLinda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, et al.
Annals of the Rheumatic Diseases|April 18, 2014
Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceRonald F van Vollenhoven, Marta Mosca, George Bertsias, et al.
Arthritis Care & Research|November 5, 2011
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseJaap Fransen, Sindhu R Johnson, Frank van den Hoogen, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2021
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisLiana Fraenkel, Joan M Bathon, Bryant R England, et al.
Arthritis Care & Research|June 8, 2021
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisLiana Fraenkel, Joan M Bathon, Bryant R England, et al.
Nature Genetics|March 11, 2008
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart, Igor Rudan, Caroline Hayward, et al.
Arthritis Care & Research|January 4, 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal DiseasesAnne R Bass, Eliza Chakravarty, Elie A Akl, et al.
Pageof 31